Androgenetic alopecia is the most common form of hair loss in both men and women, driven by a progressive miniaturization of hair follicles under androgenic influence — and it affects the majority of the population by the seventh decade of life. Hair growth helmets represent the only non-pharmacological treatment for androgenetic alopecia cleared by the US Food and Drug Administration, with a growing body of randomized controlled trial evidence supporting their efficacy across both sexes. A 16-week multicenter double-blind sham-controlled trial using a helmet-type LLLT device at 655 nm confirmed significant increases in hair density and hair thickness in androgenetic alopecia patients — with one case documenting a 50% increase in hair density at 16 weeks. (PMC7373546) A 12-month prospective trial of a home-use helmet-type LLLT device confirmed sustained hair density and shaft thickness improvements across 48 weeks of consistent use. (PMC11313483) Hair growth helmets are not a consumer trend — they are a clinically documented intervention backed by the same regulatory framework that governs pharmaceutical hair loss treatments.

Hair growth helmets stimulate follicles. What you apply to the scalp immediately after dermarolling amplifies what the helmet’s photobiomodulation initiates. The Bradceuticals Gold Hair Follicle and Adipose Stem Cell Serum is formulated specifically for the complete protocol: dermaroll the scalp first to open microchannels, apply the serum immediately to the scalp, then complete your hair growth helmet session. The adipose stem cell-derived growth factors, VEGF, bFGF, and regenerative cytokines in the serum reach the follicle bulge and dermal papilla through the open microchannels while the helmet simultaneously activates the photobiomodulation cascade in those same follicles. Two mechanisms. One compounding result.
How Hair Growth Helmets Work: The Photobiomodulation Mechanism
Hair growth helmets deliver low-level laser therapy (LLLT) — also called photobiomodulation — using red light wavelengths typically between 630 and 680 nm to penetrate the scalp and reach the hair follicle below the skin surface. The mechanism centers on the absorption of red light by cytochrome c oxidase in the mitochondrial electron transport chain. This absorption releases nitric oxide, drives ATP production, generates controlled reactive oxygen species, and activates downstream transcription factors that stimulate anagen re-entry in telogen follicles, extend the active growth phase, increase cell proliferation in existing anagen follicles, and prevent premature follicle regression. (PMC7373546)
The helmet format’s specific advantage over comb-type and handheld devices is full-scalp uniform coverage — hair growth helmets distribute photobiomodulation simultaneously across the entire treatment area, ensuring consistent follicle stimulation regardless of thinning pattern. A systematic review and meta-analysis of FDA-cleared LLLT devices confirmed that helmet-type devices showed slightly greater effectiveness than laser combs or brushes across clinical trials, despite variability in diode count, wavelength, and treatment duration. (PMC11313483)
7 Clinically Validated Ways Hair Growth Helmets Produce Results
1. Hair Growth Helmets Stimulate Anagen Re-Entry in Dormant Follicles
The most direct mechanism by which hair growth helmets reverse alopecia is activating hair follicle stem cells in the bulge region to re-enter the anagen growth phase. In androgenetic alopecia, follicles progressively spend more time in telogen — the resting phase — and less in anagen, producing shorter, finer, and eventually invisible hairs. Hair growth helmets deliver photobiomodulation energy to the mitochondria in bulge stem cells, energizing them out of their quiescent state and signaling anagen re-entry. (PMC12395542) This is why hair growth helmets are most effective for active thinning — once follicles are completely atrophied, no photobiomodulation can regenerate them. The clinical window is early-to-moderate hair loss, and starting treatment sooner consistently produces better outcomes across trials.
2. Hair Growth Helmets Increase Scalp Blood Flow and Nutrient Delivery
Hair growth helmets induce vasodilation — the widening of blood vessels in the scalp — through nitric oxide release triggered by photobiomodulation. This enhanced microcirculation delivers more oxygen, nutrients, and growth factors to the dermal papilla, the cellular command center that governs follicle cycling. Reduced scalp blood flow is a documented contributor to follicle miniaturization, and hair growth helmets partially counteract this by improving the scalp’s vascular environment across every session. The same vasodilation mechanism also explains why hair growth helmets reduce the scalp inflammation that accelerates androgenetic alopecia progression. (PMC12395542)
3. Hair Growth Helmets Reduce Scalp Inflammation That Accelerates Hair Loss
Chronic perifollicular inflammation compresses and damages the follicle bulb, contributing to progressive miniaturization in androgenetic alopecia. Hair growth helmets deliver anti-inflammatory photobiomodulation that modulates inflammatory cytokine expression at the scalp level — reducing the pro-inflammatory microenvironment that drives follicle regression. A 24-week clinical study of a helmet-type LLLT device confirmed not only improved hair density but also measurable reduction in scalp sebum secretion — the excess sebum that feeds the pro-inflammatory scalp environment associated with accelerated thinning. (PMC10564188) For people whose hair loss is accompanied by scalp sensitivity, redness, or oiliness, the anti-inflammatory effect of hair growth helmets may be as therapeutically significant as their direct follicle stimulation.
4. Hair Growth Helmets Are More Effective When Combined with Dermarolling and Growth Factor Serums
The most comprehensive non-surgical hair regrowth protocol combines hair growth helmets with dermarolling and a targeted growth factor serum — three mechanisms that compound rather than merely add to each other. Dermarolling creates scalp microchannels that deliver the Bradceuticals Gold Hair Follicle and Adipose Stem Cell Serum directly to the follicle bulge and dermal papilla. The hair growth helmet session that immediately follows amplifies cellular activity in those same follicles with photobiomodulation. Clinical evidence confirms that this combined approach — LLLT with complementary topical therapy — consistently outperforms either treatment in isolation. A study of 45 patients with female pattern hair loss found the LLLT helmet combined with topical minoxidil produced superior Ludwig classification improvements and patient satisfaction versus either treatment alone. (PMC8906269) The Bradceuticals serum protocol replaces the minoxidil layer with stem cell-derived growth factors for patients who prefer a non-pharmaceutical protocol.
5. Hair Growth Helmets Produce Measurable Results Across Both Sexes
One of the most consistent findings across hair growth helmet clinical trials is that LLLT produces significant hair density and thickness improvements in both men and women with androgenetic alopecia. A 2022 systematic review and meta-analysis of FDA-cleared LLLT devices confirmed statistically significant increases in hair density compared to sham devices in both sexes. (PMC11313483) The 16-week multicenter RCT confirmed that hair growth helmets produced significant improvements regardless of sex and regardless of the Norwood-Hamilton or Ludwig classification stage of hair loss within the trial’s inclusion range. (PMC7373546) Female pattern hair loss — historically undertreated relative to male androgenetic alopecia — responds consistently to hair growth helmets, making them one of the most equitably evidence-supported options available.
6. Hair Growth Helmets Produce Sustained Results With Long-Term Consistent Use
A 12-month prospective trial of a home-use helmet-type LLLT device — using 20-minute sessions three times per week at wavelengths of 646 to 675 nm — confirmed that hair density and shaft thickness improvements were sustained and progressive across 48 weeks of consistent use, with both global photographic assessments by blinded raters and patient-reported outcomes confirming continued improvement. (PMC11313483) This is the most important clinical implication for users of hair growth helmets: the improvements are real and they accumulate — but they require ongoing use to maintain. When hair growth helmet treatment is discontinued, androgenetic alopecia progression resumes because the underlying hormonal and genetic drivers continue unopposed. Hair growth helmets are a long-term management tool, not a short course.
7. Hair Growth Helmets Are the Only FDA-Cleared Non-Pharmacological Treatment for Pattern Hair Loss
LLLT delivered through FDA-cleared hair growth helmets is the only non-pharmacological, non-surgical treatment that has cleared the FDA regulatory framework for pattern hair loss. (PMC11313483) This distinction matters because it reflects the quality of clinical evidence required for clearance — randomized controlled trial data demonstrating both safety and efficacy — and provides a meaningful benchmark for evaluating devices in a market crowded with uncleared competitors. When selecting hair growth helmets, FDA clearance is the most important single indicator of evidence-based efficacy.
How to Use Hair Growth Helmets for Maximum Results
The Complete Bradceuticals Protocol
Step 1 — Dermaroll the scalp: Use a clean dermaroller on the scalp to create microchannels. This opens the transdermal delivery pathway for the growth factor serum.
Step 2 — Apply the serum immediately: Apply the Bradceuticals Gold Hair Follicle and Adipose Stem Cell Serum directly to the scalp through the open microchannels. The adipose stem cell-derived growth factors reach the follicle bulge and dermal papilla at the highest bioavailability window.
Step 3 — Complete your hair growth helmet session: Put on your hair growth helmet immediately following serum application. The photobiomodulation delivered by the helmet activates the same follicles the serum is simultaneously targeting at the growth factor level.
Session Protocol
Most clinical trials use 20-minute sessions, two to three times per week. The 12-month long-term trial used three sessions per week throughout 48 weeks. More frequent sessions do not produce proportionally better results and can increase scalp irritation risk — consistency within the evidence-based frequency range is more important than session frequency maximization. (PMC11313483)
Scalp preparation: Always begin with a clean scalp. Product buildup and sebum reduce light penetration depth and reduce the effectiveness of every hair growth helmet session.
Positioning: Hair growth helmets must sit securely on the head with the LED or laser array in direct contact with the scalp for full-coverage photobiomodulation.
Treatment timeline: Expect reduced shedding as the first sign of response, typically appearing in the first eight weeks. Visible density improvements require a minimum of four to six months. The 12-month clinical data confirms that results continue improving with extended consistent use beyond six months.
Who Benefits Most From Hair Growth Helmets
Early-to-moderate androgenetic alopecia: The strongest clinical evidence base. Both male and female pattern hair loss in the active thinning phase — before complete follicle atrophy — respond most consistently to hair growth helmets across randomized controlled trials.
Telogen effluvium: Stress-induced, postpartum, or illness-triggered diffuse shedding. LLLT shows emerging evidence for prolonging the anagen phase and reducing shedding in this category, though the evidence base is less developed than for androgenetic alopecia. (PMC12395542)
People seeking pharmaceutical alternatives: Hair growth helmets provide a clinically supported non-pharmacological option for people who experience side effects from finasteride or minoxidil, or who prefer to avoid systemic medications.
Anyone building a combination protocol: The additive benefit of combining hair growth helmets with dermarolling, growth factor serums, or topical minoxidil is consistently documented and represents the strongest clinical case for the device category.
Hair growth helmets are not appropriate for completely bald scalps where follicle atrophy is complete, active scarring alopecia, or conditions where follicle architecture has been irreversibly destroyed.
What to Look For When Choosing Hair Growth Helmets
FDA clearance: The non-negotiable baseline. Only FDA-cleared hair growth helmets have demonstrated evidence-based safety and efficacy through the regulatory framework.
Wavelength: Clinical evidence is strongest for red light in the 630–680 nm range. Near-infrared additions (820–880 nm) penetrate more deeply and may provide additional follicle bulge stimulation. Dual-wavelength hair growth helmets offer the broadest biological coverage.
Power output: Devices delivering less than 5 mW/cm² show minimal clinical effect. Adequate power output is essential — excessive power doesn’t improve results, but insufficient power guarantees them.
Full scalp coverage: Hair growth helmets must cover the entire scalp surface to deliver consistent photobiomodulation across all follicle populations. Partial-coverage devices produce inconsistent results across different thinning patterns.
Session time: Clinical protocols range from 8 to 30 minutes. Shorter sessions with higher power are generally equivalent to longer sessions with lower power — what matters is total energy delivery per session, not duration alone.
Frequently Asked Questions About Hair Growth Helmets
Do hair growth helmets actually work? Yes — multiple randomized controlled trials, a systematic review and meta-analysis of FDA-cleared devices, and a 12-month prospective trial all confirm that hair growth helmets produce statistically significant improvements in hair density and thickness for androgenetic alopecia in both sexes. (PMC7373546)
How long before hair growth helmets show results? Most users notice reduced shedding within eight weeks. Visible density improvements require a minimum of four to six months of consistent use. The 12-month trial data confirms continued improvement across the full 48-week study period.
Can I use hair growth helmets with other treatments? Yes — combining hair growth helmets with dermarolling and growth factor serums or topical minoxidil consistently produces superior results compared to any single intervention alone.
Are hair growth helmets safe for women? Yes — FDA-cleared hair growth helmets are approved for both men and women. Female pattern hair loss assessed by Ludwig classification improves consistently across LLLT helmet clinical trials. (PMC8906269)
Will hair loss return if I stop using hair growth helmets? Yes. Androgenetic alopecia is a progressive condition driven by ongoing hormonal factors. Hair growth helmets manage the condition rather than cure it — cessation of treatment typically results in resumption of hair loss progression over the following months.
References
- Low-Level Light Therapy Using a Helmet-Type Device for Androgenetic Alopecia: A 16-Week Multicenter RCT. PMC7373546. https://pmc.ncbi.nlm.nih.gov/articles/PMC7373546/
- Physical Treatments and Therapies for Androgenetic Alopecia. PMC11313483. https://pmc.ncbi.nlm.nih.gov/articles/PMC11313483/
- Role of Low-Level Light Therapy (LLLT) in Androgenetic Alopecia. PMC8906269. https://pmc.ncbi.nlm.nih.gov/articles/PMC8906269/
- Assessment of Effects of Low-Level Light Therapy on Scalp Condition and Hair Growth. PMC10564188. https://pmc.ncbi.nlm.nih.gov/articles/PMC10564188/
- The Use of Light-Based Therapies in the Treatment of Alopecia. PMC12395542. https://pmc.ncbi.nlm.nih.gov/articles/PMC12395542/
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a licensed dermatologist or healthcare professional before beginning any hair loss treatment. Individual results vary.
Last reviewed: March 2026
About Bradceuticals : Thuy Myers is the founder of Bradceuticals which manufactures and distributes skin care and hair regrowth serums that use growth factors from human stem cells as the catalyst for regeneration. When she is not busy running the business and maintaining blogs, she is continuing her practice as a semiconductor engineer and occasionally teaches college engineering. In her free time, she enjoys the beach, working out at the gym and hanging out with her kiddo Brad.